Centrient Pharmaceuticals
Carlos Piña Tellez has a diverse work experience in the field of human resources. Carlos started their career at BOMBARDIER in 2014 as a Labor Relations Representative. Carlos then moved to Faurecia in 2016, where they worked as an HRBP and later as an HRBP Manager until 2020. In 2020, Carlos joined Centrient Pharmaceuticals as an HRBP Manager. Carlos was later promoted to HR Director for Mexico and the USA Commercial division. In 2023, they became the HR Director for Mexico.
Carlos Piña Tellez obtained a degree in People Analytics from the University of Cambridge in 2023. Before that, they completed a specialization in Industrial Labor Relations at the Universidad Iberomexicana from 2014 to 2015. Carlos also obtained a Bachelor's degree in Law with a focus on Industrial Labor Relations from the same university between 2010 and 2014. Additionally, Carlos completed a diploma in Oral Trials at the Centro de Profesionalizacion del Poder Judicial de la Federacion, although the specific dates are not provided.
This person is not in any offices
Centrient Pharmaceuticals
2 followers
Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs). We stand proudly at the centre of modern healthcare, as a maker of essential and life-saving medicines. With our commitment to Quality, Reliability and Sustainability at the heart of everything we do, our over 1,800 employees work continuously to meet our customers’ needs. We work towards a sustainable future by actively participating in the fight against antimicrobial resistance. Founded 150 years ago as the ‘Nederlandsche Gist- en Spiritusfabriek’, our company was known as Gist Brocades and more recently DSM Sinochem Pharmaceuticals. Headquartered in Rotterdam (Netherlands), we have production facilities and sales offices in China, India, the Netherlands, Spain, the United States and Mexico. Centrient Pharmaceuticals is owned by Bain Capital Private Equity, a leading global private investment firm.